PainReform Ltd. - stock earnings

PRFX Quarterly earnings

DateEarningsRevenue
2023Q4 -4.9 million USD ? USD
2023Q3 36000 USD ? USD
2023Q2 -2.2 million USD ? USD
2023Q1 -2.2 million USD ? USD
2022Q4 -3.1 million USD 86000 USD
2022Q3 -2.1 million USD ? USD
2022Q2 -1.8 million USD ? USD
2022Q1 -1.7 million USD ? USD
2021Q4 -1.7 million USD ? USD
2021Q3 -1.8 million USD ? USD
2021Q2 -1.7 million USD ? USD
2021Q1 -2.0 million USD ? USD
2020Q4 -1.0 million USD ? USD
2020Q3 -1.1 million USD ? USD
2020Q2 -667000 USD ? USD
2020Q1 -1.3 million USD ? USD
2019Q2 -455000 USD ? USD
2019Q1 -455000 USD ? USD
2018Q4 -319750 USD ? USD
2018Q2 -208000 USD ? USD
2018Q1 -208000 USD ? USD
2017Q4 -207000 USD ? USD

PRFX Yearly earnings

DateEarningsRevenue
2023 -9.3 million USD ? USD
2022 -8.8 million USD 86000 USD
2021 -7.2 million USD ? USD
2020 -4.1 million USD ? USD
2019 -1.8 million USD ? USD
2018 -828000 USD ? USD
2017 -1.1 million USD ? USD

PRFX

Price: $0.82

52 week price:
0.42
26.41

Earnings Per Share: -7.14 USD

P/E Ratio: -0.30

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 9700

Market Capitalization: 2.9 million

Links: